AU Patent

AU2011317554B2 — Brimonidine gel compositions and methods of use

Assigned to Galderma Holding SA · Expires 2015-04-30 · 11y expired

What this patent protects

Improved topical gel compositions, such as those containing brimonidine, for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline particles after an extended period of stora…

USPTO Abstract

Improved topical gel compositions, such as those containing brimonidine, for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline particles after an extended period of storage.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011317554B2
Jurisdiction
AU
Classification
—
Expires
2015-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Galderma Holding SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.